VIAN Therapeutics

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.viantx.com/

Last Round

Seed

Nov 24, 2024

Total Funding Raised

$2.28M

Company Overview

VIAN Therapeutics is a biotechnology company developing topical antiangiogenic peptide drugs for the treatment of microvascular retinal diseases such as diabetic retinopathy and age-related macular degeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologypeptide therapeuticsretinal diseaseage-related macular degenerationAMDdiabetic retinopathyDRdiabetic macular edemaDMEeye dropsophthalmologyanti-angiogenicdrug discoveryclinical-stage biotechvirtual pharmaeye care innovation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VIAN Therapeutics Comps

Public and private peers based on sector, stage, and business model.

VIAN Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VIAN Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 24, 2024
Seed	Jun 1, 2024
Accelerator	Oct 26, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

JP Robles

Chief Executive Officer

Executive Team

VIAN Therapeutics Investors

Notable investors and investment history

VIAN Therapeutics investors
Investor	Rounds
BABEL Ventures	Seed
IndieBio	Seed, Accelerator
Ulu Ventures	Seed
SeedFolio	Seed
Social Starts	Seed
Sand Hill Angels	Seed
SOSV	Accelerator, Seed

View all Investors

VIAN Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VIAN Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VIAN Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range4

Year Founded2023

Last FundingNov 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.